These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21213109)

  • 21. Fluvastatin reduces pulmonary vein spontaneous activity through nitric oxide pathway.
    Hu YF; Chen YC; Cheng CC; Higa S; Chen YJ; Chen SA
    J Cardiovasc Electrophysiol; 2009 Feb; 20(2):200-6. PubMed ID: 18775044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sub-therapeutic doses of fluvastatin and valsartan are more effective than therapeutic doses in providing beneficial cardiovascular pleiotropic effects in rats: A proof of concept study.
    Janić M; Lunder M; France Štiglic A; Jerin A; Skitek M; Černe D; Marc J; Drevenšek G; Šabovič M
    Vascul Pharmacol; 2017 Dec; 99():45-52. PubMed ID: 28951255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluvastatin-induced reduction of oxidative stress ameliorates diabetic cardiomyopathy in association with improving coronary microvasculature.
    Shida T; Nozawa T; Sobajima M; Ihori H; Matsuki A; Inoue H
    Heart Vessels; 2014 Jul; 29(4):532-41. PubMed ID: 23979266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluvastatin increases prostacyclin and decreases endothelin production by human umbilical vein endothelial cells.
    Seeger H; Mueck AO; Lippert TH
    Int J Clin Pharmacol Ther; 2000 May; 38(5):270-2. PubMed ID: 10839471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein B of low-density lipoprotein impairs nitric oxide-mediated endothelium-dependent relaxation in rat mesenteric arteries.
    Zhang Y; Zhang W; Edvinsson L; Xu CB
    Eur J Pharmacol; 2014 Feb; 725():10-7. PubMed ID: 24444440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The statins fluvastatin and pravastatin exert anti-flushing effects by improving vasomotor dysfunction through nitric oxide-mediated mechanisms in ovariectomized animals.
    Shuto H; Tominaga K; Yamauchi A; Ikeda M; Kusaba K; Mitsunaga D; Hirabara Y; Egawa T; Takano Y; Kataoka Y
    Eur J Pharmacol; 2011 Jan; 651(1-3):234-9. PubMed ID: 21114974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles.
    Tiefenbacher CP; Friedrich S; Bleeke T; Vahl C; Chen X; Niroomand F
    Am J Physiol Heart Circ Physiol; 2004 Apr; 286(4):H1425-32. PubMed ID: 14644762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
    Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
    Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
    Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
    J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of fluvastatin on endothelium-derived hyperpolarizing factor- and nitric oxide-mediated relaxations in arteries of hypertensive rats.
    Kansui Y; Fujii K; Goto K; Abe I; Iida M
    Clin Exp Pharmacol Physiol; 2004; 31(5-6):354-9. PubMed ID: 15191411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preservation of endothelial function by the HMG-CoA reductase inhibitor fluvastatin through its lipid-lowering independent antioxidant properties in atherosclerotic rabbits.
    Mitani H; Egashira K; Ohashi N; Yoshikawa M; Niwa S; Nonomura K; Nakashima A; Kimura M
    Pharmacology; 2003 Jul; 68(3):121-30. PubMed ID: 12784083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelium-specific overexpression of human IC53 downregulates endothelial nitric oxide synthase activity and elevates systolic blood pressure in mice.
    Zhuo ML; Huang Y; Chen JZ; Sun LH; Yang RF; Chen HZ; Lv X; Li HL; Wei YS; Liu G; Zhang R; Ma TM; Cai H; Hui RT; Liu DP; Liang CC
    Cardiovasc Res; 2009 Nov; 84(2):292-9. PubMed ID: 19541669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sterol regulatory element binding protein-mediated effect of fluvastatin on cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase transcription.
    Mascaró C; Ortiz JA; Ramos MM; Haro D; Hegardt FG
    Arch Biochem Biophys; 2000 Feb; 374(2):286-92. PubMed ID: 10666309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a 3-year therapy with the 3-hydroxy-3-methylglutaryl coenzyme a reductase-inhibitor fluvastatin on endothelial function and distensibility of large arteries in hypercholesterolemic renal transplant recipient.
    Kosch M; Barenbrock M; Suwelack B; Schaefer RM; Rahn KH; Hausberg M
    Am J Kidney Dis; 2003 May; 41(5):1088-96. PubMed ID: 12722044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prolactin family hormones regulate vascular tone through NO and prostacyclin production in isolated rat aortic rings.
    Gonzalez C; Rosas-Hernandez H; Jurado-Manzano B; Ramirez-Lee MA; Salazar-Garcia S; Martinez-Cuevas PP; Velarde-Salcedo AJ; Morales-Loredo H; Espinosa-Tanguma R; Ali SF; Rubio R
    Acta Pharmacol Sin; 2015 May; 36(5):572-86. PubMed ID: 25891087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluvastatin prevents renal dysfunction and vascular NO deficit in apolipoprotein E-deficient mice.
    Gervais M; Pons S; Nicoletti A; Cosson C; Giudicelli JF; Richer C
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):183-9. PubMed ID: 12588757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced nitric oxide-mediated relaxation and endothelial nitric oxide synthase expression in the tail arteries of streptozotocin-induced diabetic rats.
    Mokhtar SS; Vanhoutte PM; Leung SW; Suppian R; Yusof MI; Rasool AH
    Eur J Pharmacol; 2016 Feb; 773():78-84. PubMed ID: 26825543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statins inhibit high glucose-mediated neutrophil-endothelial cell adhesion through decreasing surface expression of endothelial adhesion molecules by stimulating production of endothelial nitric oxide.
    Omi H; Okayama N; Shimizu M; Fukutomi T; Imaeda K; Okouchi M; Itoh M
    Microvasc Res; 2003 Mar; 65(2):118-24. PubMed ID: 12686169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disrupted eNOS activity and expression account for vasodilator dysfunction in different stage of sepsis.
    Hu S; Pi Q; Xu X; Yan J; Guo Y; Tan W; He A; Cheng Z; Luo S; Xia Y
    Life Sci; 2021 Jan; 264():118606. PubMed ID: 33091444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluvastatin upregulates inducible nitric oxide synthase expression in cytokine-stimulated vascular smooth muscle cells.
    Chen H; Ikeda U; Shimpo M; Ikeda M; Minota S; Shimada K
    Hypertension; 2000 Dec; 36(6):923-8. PubMed ID: 11116101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.